IART Q1 2021 Earnings — Integra LifeSciences Holdings Corporation Revenue & Financial Results | Market Cap Arena

IARTIntegra LifeSciences Holdings Corporation

$738M

Q1 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$360M+1.6% YoY

Gross Profit

$214M59.5% margin

Operating Income

$31M8.5% margin

Net Income

$45M12.6% margin

EPS (Diluted)

$0.53

QoQ Revenue Growth

-7.4%

Cash Flow

Operating Cash Flow

$69M

Free Cash Flow

$62M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$3.7B

Total Liabilities

$2.2B

Stockholders' Equity

$1.5B

Cash & Equivalents

$409M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$360M	$354M	+1.6%
Gross Profit	$214M	$221M	-3.0%
Operating Income	$31M	$27M	+13.3%
Net Income	$45M	$9M	+394.5%

Revenue Segments

Codman Specialty Surgical

$241M67%

Tissue Technologies

$119M33%

Geographic Segments

UNITED STATES

$248M69%

Asia Pacific

$47M13%

Europe

$46M13%

Rest Of World

$19M5%